Japan
Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old
March 19, 2020Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy
Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and …
Japan welcomes approval of ViiV’s Dovato for HIV-1
January 17, 2020Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma
Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …
China’s viral pneumonia spreads to Japan
January 17, 2020Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia
A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …
Lundbeck and Takeda’s depression drug approved in Japan
September 20, 2019Medical Communications, Sales and Marketing Japan, Lundbeck, Takeda, major depressive disorder, pharma
Takeda and Lundbeck have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has chosen to authorise their drug …
Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours
June 18, 2019Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma
Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …
Takeda scores Japanese Entyvio approval in Crohn’s disease
May 22, 2019Research and Development, Sales and Marketing Crohn’s disease, Entyvio, Japan, crohn's disease, pharma
Takeda has announced that Japan’s drug regulator, the Ministry of Health, Labour and Welfare (MHLW), has approved Entyvio (vedolizumab) in …
Novartis’ Kymriah to be covered by Japan’s national insurance system
May 16, 2019Medical Communications, Sales and Marketing CAR T, CAR-T, Japan, Kymriah, Novartis, pharma
Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical …
US prescription drugs most expensive in world, analysis shows
May 8, 2019Research and Development Drug pricing, Japan, Ontario, UK, US, prescription drugs
Brand name prescription drugs cost on average 4.3 times more in the United States than in the UK, according to …
Takeda opens R&D facility in San Diego, California
May 2, 2019Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
Japanese court orders public health campaigner to pay ¥3.3 million to anti-vaccine researcher
March 27, 2019Medical Communications, Research and Development HPV, Japan, anti vaxx, anti-vaccine, public health, vaccines
Dr Riko Muranaka, a researcher and journalist who has campaigned against misinformation surrounding vaccines, has been ordered to pay ¥3.3 …
Japan awards AbbVie’s Skyrizi with first approval, in 4 psoriasis indications
March 27, 2019Research and Development, Sales and Marketing AbbVie, Japan, Skyrizi, pharma, psoriasis
AbbVie has announced that its interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has been awarded approval in Japan from the nation’s Ministry …
Sunovion CMO Dr Antony Loebel made company’s new CEO
March 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, CMO, Japan, medicine, psychiatry, sunovion
Japanese drugmaker Sunovion Pharmaceuticals has made their current Chief Medical Officer (CMO) the company’s new Chief Executive Officer (CEO). Dr …
Japanese researchers to trial stem cell therapy in four patients with serious spinal injuries
February 19, 2019Manufacturing and Production Japan, Keio University, Parkinson's, cell therapy, iPS
The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …
UK-Japan partnership to see collaboration on incurable diseases, green technology and AI
January 11, 2019Medical Communications AI, Japan, MRC, UK, international partnership, medicine, technology
A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …
Amgen and UCB’s Evenity approved in Japan for osteoporosis
January 9, 2019Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma
Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …
Latest content
